- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Biomimetic Nanoparticles for the Treatment of Hematologic Malignancies ; year:2021
Advanced nanoBiomed research ; (2021)
- Creator
-
Powsner, Emily H.
Harris, Jenna C.
Day, Emily S.
- DOI
-
10.1002/anbr.202000047
- URN
-
urn:nbn:de:101:1-2021020908145411690044
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Powsner, Emily H.
- Harris, Jenna C.
- Day, Emily S.
Other Objects (12)
Hematologic malignancies
Bispecific Antibodies in the Treatment of Hematologic Malignancies
Bortezomib for the Treatment of Hematologic Malignancies: 15 Years Later
Hematologic malignancies : acute leukemias ; with 51 tables
COVID-19 in Hematologic Malignancies: Big Challenges
Targeting CD22 for B-cell hematologic malignancies
Identification and characterization of T Lymphocytes for the treatment of hematologic malignancies
Biological relevance of alternative splicing in hematologic malignancies
Genomic testing for germline predisposition to hematologic malignancies
Antifungal Stewardship Interventions in Patients with Hematologic Malignancies
CAR-T cell combination therapies in hematologic malignancies
Immunotherapy in hematologic malignancies: past, present, and future
Hematologic malignancies
Bispecific Antibodies in the Treatment of Hematologic Malignancies
Bortezomib for the Treatment of Hematologic Malignancies: 15 Years Later
Hematologic malignancies : acute leukemias ; with 51 tables
COVID-19 in Hematologic Malignancies: Big Challenges
Targeting CD22 for B-cell hematologic malignancies
Identification and characterization of T Lymphocytes for the treatment of hematologic malignancies
Biological relevance of alternative splicing in hematologic malignancies
Genomic testing for germline predisposition to hematologic malignancies
Antifungal Stewardship Interventions in Patients with Hematologic Malignancies
CAR-T cell combination therapies in hematologic malignancies
Immunotherapy in hematologic malignancies: past, present, and future
Hematologic malignancies
Bispecific Antibodies in the Treatment of Hematologic Malignancies
Bortezomib for the Treatment of Hematologic Malignancies: 15 Years Later
Hematologic malignancies : acute leukemias ; with 51 tables
COVID-19 in Hematologic Malignancies: Big Challenges
Targeting CD22 for B-cell hematologic malignancies
Identification and characterization of T Lymphocytes for the treatment of hematologic malignancies
Biological relevance of alternative splicing in hematologic malignancies
Genomic testing for germline predisposition to hematologic malignancies
Antifungal Stewardship Interventions in Patients with Hematologic Malignancies
CAR-T cell combination therapies in hematologic malignancies